Skip to main content
Notice2025-13564

Hexamethylenetetramine From the People's Republic of China: Final Affirmative Countervailing Duty Determination

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 18, 2025

Issuing agencies

Commerce DepartmentInternational Trade Administration

Abstract

The U.S. Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of hexamethylenetetramine (hexamine) from the People's Republic of China (China). The period of investigation is January 1, 2023, through December 31, 2023.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 136 (Friday, July 18, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 136 (Friday, July 18, 2025)]
[Notices]
[Pages 33923-33925]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-13564]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[C-570-181]


Hexamethylenetetramine From the People's Republic of China: Final 
Affirmative Countervailing Duty Determination

AGENCY: Enforcement and Compliance, International Trade Administration, 
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) determines that 
countervailable subsidies are being provided to producers and exporters 
of hexamethylenetetramine (hexamine) from the People's Republic of 
China (China). The period of investigation is January 1, 2023, through 
December 31, 2023.

DATES: Applicable July 18, 2025.

FOR FURTHER INFORMATION CONTACT: Eliza DeLong, AD/CVD Operations, 
Office V, Enforcement and Compliance, International Trade 
Administration, U.S. Department of Commerce, 1401 Constitution Avenue 
NW, Washington, DC 20230; telephone: (202) 482-3878.

SUPPLEMENTARY INFORMATION:

Background

    On March 7, 2025, Commerce published in the Federal Register its 
Preliminary Determination in the countervailing duty (CVD) 
investigation hexamine from China and invited interested parties to 
comment.\1\ In the Preliminary Determination, and in accordance with 
section 705(a)(1) of the Tariff Act of 1930, as amended (the Act), and 
19 CFR 351.210(b)(4), Commerce aligned the final CVD determination with 
the final determination in the less-than-fair-value investigation of 
hexamine from China.\2\
---------------------------------------------------------------------------

    \1\ See Hexamethylenetetramine from the People's Republic of 
China: Preliminary Affirmative Countervailing Duty Determination and 
Alignment of Final Determination with Final Antidumping Duty 
Determination, 90 FR 11508 (March 7, 2025) (Preliminary 
Determination), and accompanying Preliminary Decision Memorandum 
(PDM).
    \2\ See Preliminary Determination, 90 FR at 11509.
---------------------------------------------------------------------------

    For a complete description of the events that followed the 
Preliminary

[[Page 33924]]

Determination, see the Issues and Decision Memorandum.\3\ The Issues 
and Decision Memorandum is a public document and is on file 
electronically via Enforcement and Compliance's Antidumping and 
Countervailing Duty Centralized Electronic Service System (ACCESS). 
ACCESS is available to registered users at <a href="https://access.trade.gov">https://access.trade.gov</a>. In 
addition, a complete version of the Issues and Decision Memorandum can 
be accessed directly at <a href="https://access.trade.gov/public/FRNoticesListLayout.aspx">https://access.trade.gov/public/FRNoticesListLayout.aspx</a>.
---------------------------------------------------------------------------

    \3\ See Memorandum, ``Decision Memorandum for the Final 
Affirmative Determination in the Countervailing Duty Investigation 
of Hexamethylenetetramine from the People's Republic of China,'' 
dated concurrently with, and hereby adopted by, this notice (Issues 
and Decision Memorandum).
---------------------------------------------------------------------------

Scope of the Investigation

    The product covered by this investigation is hexamine from China. 
For a complete description of the scope of this investigation, see 
Appendix I.

Scope Comments

    We received no comments from interested parties on the scope of the 
investigation as it appeared in the Preliminary Determination. 
Therefore, we made no changes to the scope of the investigation.

Verification

    Because the non-responsive companies did not participate in this 
investigation and because the Government of China (GOC) did not provide 
information Commerce requested, Commerce did not conduct a verification 
in this investigation.

Analysis of Subsidy Programs and Comments Received

    The subsidy programs under investigation, and the issues raised in 
the case brief by the GOC are discussed in the Issues and Decision 
Memorandum. For a list of the issues raised by interested parties and 
addressed in the Issues and Decision Memorandum, see Appendix II to 
this notice.

Methodology

    Commerce conducted this investigation in accordance with section 
701 the Act. For each of the subsidy programs found to be 
countervailable, Commerce determines that there is a subsidy, i.e., a 
financial contribution by an ``authority'' that gives rise to a benefit 
to the recipient, and that the subsidy is specific.\4\ For a full 
description of the methodology underlying our final determination, see 
the Issues and Decision Memorandum.
---------------------------------------------------------------------------

    \4\ See sections 771(5)(B) and (D) of the Act regarding 
financial contribution; see also section 771(5)(E) of the Act 
regarding benefit; and section 771(5A) of the Act regarding 
specificity.
---------------------------------------------------------------------------

    In making this final determination, Commerce relied on facts 
otherwise available and, because it finds that certain respondents and 
the Government of China did not act to the best of their ability to 
respond to Commerce's requests for information, Commerce drew an 
adverse inference, where appropriate, in selecting among the facts 
otherwise available.\5\ For a full discussion of our application of 
adverse facts available (AFA), see the Preliminary Determination,\6\ 
and the Issues and Decision Memorandum section entitled ``Use of Facts 
Otherwise Available and Application of Adverse Inferences.''
---------------------------------------------------------------------------

    \5\ See sections 776(a) and (b) of the Act.
    \6\ See Preliminary Determination PDM at 3-5.
---------------------------------------------------------------------------

Changes Since the Preliminary Determination

    Based on our review and analysis of the comments submitted in case 
briefs, we made no methodological changes to our determination.\7\
---------------------------------------------------------------------------

    \7\ Although we made no methodological changes to our 
Preliminary Determination, we updated our selection of the AFA rate 
for grant programs to reflect a more recent rate for the ``Equipment 
Grant'' from Cabinets from China. See Wooden Cabinets and Vanities 
and Components Thereof from the People's Republic of China: Final 
Affirmative Countervailing Duty Determination, 85 FR 11962 (February 
28, 2020) (Cabinets from China), and accompanying Issues and 
Decision Memorandum.
---------------------------------------------------------------------------

All-Others Rate

    As discussed in the Preliminary Determination, Commerce based the 
selection of the all-others rate on the countervailable subsidy rate 
established for the mandatory respondents in accordance with section 
705(c)(5)(A)(ii) of the Act.\8\ We made no changes to the selection of 
this rate for this final determination.
---------------------------------------------------------------------------

    \8\ See Preliminary Determination.
---------------------------------------------------------------------------

Final Determination

    Commerce determines that the following estimated countervailable 
subsidy rates exist for the period January 1, 2023, through December 
31, 2023:

------------------------------------------------------------------------
                                                           Subsidy rate
                         Company                            (percent ad
                                                             valorem)
------------------------------------------------------------------------
Changzhou Highassay Chemical Co.........................        * 420.73
China Bluestar International Chemical Co., Ltd..........        * 420.73
Fengchen Group Co., Ltd.................................        * 420.73
Hutubi Ruiyuantong Chemicals Co., Ltd...................        * 420.73
Jiangsu Guotai Guomian Trading..........................        * 420.73
Jiaozuo Runhua Chemical Industry Co.....................        * 420.73
Qingdao Sun Chemical Corp. Ltd..........................        * 420.73
Runhua Chemical Industry................................        * 420.73
Shandong Aojin Chemical Technology Co., Ltd.............        * 420.73
All Others..............................................          420.73
------------------------------------------------------------------------
* Rate based on facts available with adverse inferences.

Disclosure

    Normally, Commerce discloses its calculations performed in 
connection with the final determination to interested parties within 
five days of its public announcement, or if there is no public 
announcement, within five days of the date of publication of this 
notice, in accordance with 19 CFR 351.224(b). However, because Commerce 
applied facts available with adverse inferences in the calculation of 
the benefit for the non-responsive companies, and the applied AFA rates 
are based on rates calculated in prior proceedings, there are no 
calculations to disclose.

Suspension of Liquidation

    As a result of our Preliminary Determination, and pursuant to 
sections 703(d)(1)(B) and (d)(2) of the Act, Commerce instructed U.S. 
Customs and Border Protection (CBP) to collect cash deposits and 
suspend liquidation of entries of subject merchandise from China that 
were entered, or withdrawn from warehouse, for consumption on or after 
March 7, 2025, the date of publication of the Preliminary Determination 
in the Federal Register.\9\ In accordance with section 703(d) of the 
Act, we instructed CBP to discontinue the suspension of liquidation of 
all entries of subject merchandise entered or withdrawn from warehouse, 
on or after July 5, 2025, but to continue the suspension of liquidation 
of all entries of subject merchandise from March 7, 2025, through July 
4, 2025.
---------------------------------------------------------------------------

    \9\ See Preliminary Determination, 90 FR at 11509.
---------------------------------------------------------------------------

    If the U.S. International Trade Commission (ITC) issues a final 
affirmative injury determination, we will issue a CVD order, reinstate 
the suspension of liquidation under section 706(a) of the Act, and 
require a cash deposit of estimated countervailing duties for entries 
of subject merchandise in the amounts indicated above. If the ITC 
determines that material injury, or threat of material injury, does not 
exist, this proceeding will be terminated, and

[[Page 33925]]

all estimated duties deposited, or securities posted as a result of the 
suspension of liquidation will be refunded or canceled.

ITC Notification

    In accordance with section 705(d) of the Act, we will notify the 
ITC of our final affirmative determination that countervailable 
subsidies are being provided to producers and exporters of hexamine 
from China. As Commerce's final determination is affirmative, in 
accordance with section 705(b) of the Act, the ITC will determine, 
within 45 days, whether the domestic industry in the United States is 
materially injured, or threatened with material injury, by reason of 
imports of hexamine from China. In addition, we are making available to 
the ITC all non-privileged and non-proprietary information in our 
files, provided the ITC confirms that it will not disclose such 
information, either publicly or under administrative protective order 
(APO), without the written consent of the Assistant Secretary for 
Enforcement and Compliance.
    If the ITC determines that material injury or threat of material 
injury does not exist, this proceeding will be terminated, and all cash 
deposits will be refunded. If the ITC determines that such injury does 
exist, Commerce will issue a CVD order directing CBP to assess, upon 
further instruction by Commerce, countervailing duties on all imports 
of the subject merchandise that are entered, or withdrawn from 
warehouse, for consumption on or after the effective date of the 
suspension of liquidation, as discussed above in the ``Suspension of 
Liquidation'' section.

Administrative Protective Order

    In the event that the ITC issues a final negative injury 
determination, this notice will serve as the only reminder to parties 
subject to the APO of their responsibility concerning the destruction 
of proprietary information disclosed under APO, in accordance with 19 
CFR 351.305(a)(3). Timely written notification of the return/
destruction of APO materials or conversion to judicial protective order 
is hereby requested. Failure to comply with the regulations and terms 
of an APO is a violation which is subject to sanction.

Notification to Interested Parties

    We are issuing and publishing these results in accordance with 
sections 705(d) and 777(i) of the Act, and 19 CFR 351.210(c).

    Dated: July 14, 2025.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the 
non-exclusive functions and duties of the Assistant Secretary for 
Enforcement and Compliance.

Appendix I

Scope of the Investigation

    The scope of this investigation covers hexamine in granular 
form, with a particle size of 5 millimeters or less, whether 
stabilized or unstabilized, whether or not blended, mixed, 
pulverized, or grounded with other products, containing 50 percent 
or more hexamine by weight.
    Hexamine is the common name for hexamethylene tetramine 
(Chemical Abstract Service #100-97-0), and is also referred to as 
1,3,5,7-tetraazaadamantanemethenamine; HMT; HMTA; 1,3,5,7-
tetraazatricyclo {3.3.1.13,7{time}  decane; 1,3,5,7-tetraaza 
adamantane; hexamethylenamine. Hexamine has the chemical formula C6 
H12 N4.
    Granular hexamine that has been blended with other product(s) is 
included in this scope when the resulting mix contains 50 percent or 
more of hexamine by weight, regardless of whether it is blended with 
inert additives, co-reactants, or any additives that undergo self-
condensation.
    Subject merchandise includes merchandise matching the above 
description that has been processed in a third country, including by 
commingling, diluting, adding or removing additives, or performing 
any other processing that would not otherwise remove the merchandise 
from the scope of the investigation if performed in the subject 
country.
    Merchandise covered by the scope of this investigation can be 
classified in the Harmonized Tariff Schedule (HTSUS) of the United 
States under the subheading 2933.69.5000. The HTSUS subheading and 
Chemical Abstracts Service registry number are provided for 
convenience and customs purposes only; however, the written 
description of the scope is dispositive.

Appendix II

List of Topics Discussed in the Issues and Decision Memorandum

I. Summary
II. Background
III. Use of Facts Otherwise Available and Adverse Inferences
IV. Analysis of Programs
V. Discussion of the Issues
    Comment 1: Whether Commerce Should Find Non-Use or Provision of 
Labor for Less than Adequate Remuneration (LTAR)
    Comment 2: Countervailability of Labor for LTAR
VI. Recommendation

[FR Doc. 2025-13564 Filed 7-17-25; 8:45 am]
BILLING CODE 3510-DS-P


</pre></body>
</html>
Indexed from Federal Register on July 18, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.